ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,300Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 198

$662K Total Retail Price of All Prescriptions

Rank: 36 out of 198

485 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,341 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 530 507 1 4
LEVOTHYROXINE SODIUM 521 514 2 1
SIMVASTATIN 330 306 3 2
OMEPRAZOLE 308 268 4 3
LISINOPRIL 293 283 5 6
FUROSEMIDE 288 273 6 5
WARFARIN SODIUM 263 248 7 7
POTASSIUM CHLORIDE 229 228 8 9
ATENOLOL 219 199 9 17
HYDROCODONE-ACETAMINOPHEN 199 167 S3 10 8
GLIMEPIRIDE 189 174 11 35
ALENDRONATE SODIUM 187 167 12 21
ATORVASTATIN CALCIUM 185 181 13 12
ZOLPIDEM TARTRATE 170 139 14 22
METOPROLOL SUCCINATE 166 166 15 11
BYSTOLIC 162 162 16 58
PRAVASTATIN SODIUM 162 162 16 19
METFORMIN HCL ER 160 160 18 64
MELOXICAM 154 126 19 30
CITALOPRAM HBR 137 134 20 20
TRAMADOL HCL 136 136 21 15
SYNTHROID 126 114 22 36
HYDROCHLOROTHIAZIDE 123 117 23 16
SPIRONOLACTONE 123 111 23 37
LOSARTAN POTASSIUM 118 116 25 18
LOVASTATIN 117 104 26 70
CRESTOR 113 100 27 26
CYMBALTA 113 90 27 48
ZETIA 111 88 29 68
TAMSULOSIN HCL 109 109 30 27
JANUVIA 106 106 31 86
CIPROFLOXACIN HCL 103 100 32 55
GABAPENTIN 95 79 33 14
POLYETHYLENE GLYCOL 3350 85 57 34 41
DONEPEZIL HCL 84 84 35 28
RAMIPRIL 81 81 36 72
METOPROLOL TARTRATE 80 71 37 10
CELEBREX 79 79 38 59
ISOSORBIDE MONONITRATE ER 78 77 39 60
METFORMIN HCL 77 72 40 13
TRAMADOL HCL-ACETAMINOPHEN 77 73 40 185
SERTRALINE HCL 77 62 40 25
SPIRIVA 77 77 40 63
FENOFIBRATE 75 75 44 61
CLOPIDOGREL 73 73 45 42
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 46 99
BISOPROLOL FUMARATE 70 53 47 87
CARVEDILOL 70 61 47 24
ALLOPURINOL 70 62 47 23
NAMENDA 67 54 50 33
PANTOPRAZOLE SODIUM 66 49 51 31
FINASTERIDE 64 64 52 94
INSULIN SYRINGE 62 56 53 95
AMOXICILLIN 61 56 54 130
LOSARTAN-HYDROCHLOROTHIAZIDE 58 55 55 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 55 38
CARBIDOPA-LEVODOPA 55 55 57 71
FLUTICASONE PROPIONATE 55 53 57 39
LYRICA 54 54 59 91
LANTUS 54 49 59 46
TRAZODONE HCL 53 40 61 50
AMITRIPTYLINE HCL 52 52 R 62 69
DIOVAN 51 51 63 34
BUSPIRONE HCL 50 50 64 132
ESCITALOPRAM OXALATE 50 38 64 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.